Skip to content

Treatment of single and multiple soft tissue recessions of Miller classes I, II and III with a new reconstructive tissue matrix using the coronally displaced tunnel technique. A prospective clinical two-center cohort study.

Treatment of single and multiple soft tissue recessions of Miller classes I, II and III with a new reconstructive tissue matrix using the coronally displaced tunnel technique. A prospective clinical two-center cohort study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023201
Enrollment
40
Registered
2020-11-09
Start date
2020-11-19
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GINGIVAREZESSIONEN K05

Interventions

Group 1: 40 Patients receive recession coverage by means of a coronally shifted tunnel technique using the acellular dermal matrix.

Sponsors

Oral Reconstruction Foundation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Male and female persons over the age of 18 in the sense of the age of majority, as well as full legal capacity (§§ 2 BGB). 2. Periodontal and general medical healthy patients. 3. Single or multiple ginigvar recessions of the upper and / or lower jaw (Miller classes I to III). 4. The patient was informed about the follow-up examinations relevant to the study and agrees to participate in them. 5. Good oral hygiene and patient plaque control (FMPS <20%).

Exclusion criteria

Exclusion criteria: 1. Miller class IV gingival recession. 2. General diseases that contradict dental implant therapy (e.g. diabetes mellitus that has not been discontinued). 3. Any contraindications to oral surgery. 4. Tobacco consumption (in the form of cigarettes, chewing tobacco, etc.). Systemic diseases (diseases of the cardiovascular system, bleeding disorders (including the use of anticoagulants), metabolic bone diseases, chemotherapy or radiation, chronic inflammation, metabolic or systemic dysfunction associated with lesions and / or altered bone healing). 6. Taking drugs that block or alter bone healing. 7. Uncontrolled parafunctions (bruxism (clenching of the teeth, grinding)). 8. Intraoral infections. 9.Dysfunctions / diseases / conditions that impede the patient's ability to maintain adequate oral hygiene. 10. Conditions and circumstances which, according to the evaluation of the study director or his deputy, would hinder the completion of the study participation and the analysis of the results (e.g. previous history of non-compliance and / or unreliability).

Design outcomes

Primary

MeasureTime frame
Evaluation root coverage after 12 months (mean Root Coverage-mRC in %)

Secondary

MeasureTime frame
Digital evaluation of the soft tissue volume (by means of an extra-oral scan of plaster models) before, as well as six and twelve months post-augmentation

Countries

Germany, Switzerland

Contacts

Public ContactGerhard Iglhaut

UNIVERSITÄTSKLINIKUM FREIBURG Department für Zahn-, Mund- und Kieferheilkunde Klinik für Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen

gerhard.iglhaut@uniklinik-freiburg.de0761 270 49820

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026